KIR2DL3 Antikörper (AA 19-161)
Kurzübersicht für KIR2DL3 Antikörper (AA 19-161) (ABIN361088)
Target
Alle KIR2DL3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 19-161
-
Verwendungszweck
- Human CD158b2/KIR2DL3 antibody
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant human KIR2DL3 (19-161aa) purified from E. coli
-
Isotyp
- IgG2a kappa
-
-
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) (AA 42-140) antibody
KIR2DL3 Reaktivität: Human ELISA, ICC, IF (p), IF (cc), IHC (fro), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) antibodyKIR2DL3 Reaktivität: Human, Maus WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) (AA 22-245) antibodyKIR2DL3 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) antibodyKIR2DL3 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) (AA 22-245) antibodyKIR2DL3 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) (AA 1-341) antibodyKIR2DL3 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) (Internal Region) antibodyKIR2DL3 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) (AA 19-161) antibodyKIR2DL3 Reaktivität: Human WB, ELISA, IF, ICC Wirt: Maus Monoclonal 190IIC311 unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) (AA 19-161) antibodyKIR2DL3 Reaktivität: Human WB, ELISA, FACS Wirt: Maus Monoclonal 190IIC311 unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) (AA 22-342) antibodyKIR2DL3 Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Recommended dilution 1:1000(W.B), (FACS)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- KIR2DL3 (Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3))
-
Andere Bezeichnung
- CD158b2/KIR2DL3
-
Hintergrund
- Reacts with extracellular domain of the KIR2DL3, a member of the Killer cell immunoglobulin-liKe receptor(KIR) family. The KIR family consists of transmembrane glycoproteins of the Ig superfamily expressed on human NK cells and a subset of human T cells which they are involved in recognition of either MHC class I molecules or unKnown ligand on target cells and inhibit cytotoxic activities.
-
NCBI Accession
- NP_055326
-
Pathways
- Cancer Immune Checkpoints
Target
-
